Search research articles
Contact Us
Filters
Showing results (51-60 of 141) with videos related to
Page
of 15
Sort By:
Cancer Research Communications
|
January 9, 2025
Evaluating Ovarian Cancer Risk-Reducing Salpingectomy Acceptance: A Survey
Alexandra Lukey, Ramlogan Sowamber, David Huntsman, et al.
The Journal of Pathology
|
December 8, 2009
Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma
Jason Madore, Fengge Ren, Ali Filali-Mouhim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers
Stephen Chia, Brian Norris, Caroline Speers, et al.
Experimental Cell Research
|
August 23, 2005
Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro
Paulo Ferreira, Maria José Oliveira, Eliana Beraldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2006
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index
Grace M Callagy, Paul D Pharoah, Sarah E Pinder, et al.
Scientific Reports
|
October 11, 2016
Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation
Patrícia Oliveira, Joana Carvalho, Sara Rocha, et al.
Plos One
|
October 3, 2009
MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary
Cheng-Han Lee, Subbaya Subramanian, Andrew H Beck, et al.
The American Journal of Pathology
|
February 19, 2013
The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma
Zsuzsanna Lichner, Andreas Scorilas, Nicole M A White, et al.
Human Mutation
|
April 23, 2002
Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred
Carla Oliveira, Maria Cristina Bordin, Nicola Grehan, et al.
Human Molecular Genetics
|
September 23, 2003
E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells
Gianpaolo Suriano, Maria José Oliveira, David Huntsman, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 141) with videos related to
Sort By:
Page
of 15
Cancer Research Communications
|
January 9, 2025
Evaluating Ovarian Cancer Risk-Reducing Salpingectomy Acceptance: A Survey
Alexandra Lukey, Ramlogan Sowamber, David Huntsman, et al.
The Journal of Pathology
|
December 8, 2009
Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma
Jason Madore, Fengge Ren, Ali Filali-Mouhim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers
Stephen Chia, Brian Norris, Caroline Speers, et al.
Experimental Cell Research
|
August 23, 2005
Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro
Paulo Ferreira, Maria José Oliveira, Eliana Beraldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2006
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index
Grace M Callagy, Paul D Pharoah, Sarah E Pinder, et al.
Scientific Reports
|
October 11, 2016
Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation
Patrícia Oliveira, Joana Carvalho, Sara Rocha, et al.
Plos One
|
October 3, 2009
MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary
Cheng-Han Lee, Subbaya Subramanian, Andrew H Beck, et al.
The American Journal of Pathology
|
February 19, 2013
The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma
Zsuzsanna Lichner, Andreas Scorilas, Nicole M A White, et al.
Human Mutation
|
April 23, 2002
Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred
Carla Oliveira, Maria Cristina Bordin, Nicola Grehan, et al.
Human Molecular Genetics
|
September 23, 2003
E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells
Gianpaolo Suriano, Maria José Oliveira, David Huntsman, et al.
Page
of 15